A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

A few common medications, like statins or drugs to treat high blood pressure, appear to help lower the risk for dementia. But others, including some you can buy over the counter, may increase the risk ...

Health Canada has approved a second drug that targets the underlying cause of Alzheimer’s disease, a development that could ...

A major review has found that new Alzheimer's drugs hailed as breakthroughs may offer only limited benefits for patients. Treatments including donanemab and lecanemab have been shown in clinical ...

This is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved ...

Drugs used to tackle shingles, erectile dysfunction, and motor neurone disease could have surprising benefits in the fight against Alzheimer’s. New research suggests shingles vaccine Zostavax and ...

A new, large-scale review of studies on medications aimed at slowing the progress of early Alzheimer's disease has drawn a sobering conclusion: the drugs don't work. Alzheimer's affects more than 7 ...

A medication that could help treat early stages of Alzheimer's disease is on track to be approved for manufacturing and sales in Japan after being endorsed by a health ministry expert panel on Aug. 21 ...

A new review of preclinical studies suggests GLP-1 drugs like Ozempic may reduce key proteins linked to Alzheimer’s disease.